Abstract

BackgroundMortality and morbidity among children with Respiratory Syncytial Virus (RSV) bronchiolitis is higher among infants born prematurely and those with chronic lung or congenital heart disease. Palivizumab is a monoclonal...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call